Launch of 60-Count Sleep Gummies into the Middle Eastern Markets Drives Further Growth of Delivra Health Brands' Dream Water(R) Brand
Delivra Health Brands Inc. (DHBUF) has announced the expansion of its Dream Water® brand into Middle Eastern markets through the launch of its new 60-Count Sleep Gummies. The product will be distributed through the company's Kuwait-based distributor and is expected to be available in local markets by July 2025.
This strategic expansion builds upon Dream Water's existing success with sleep gummies in Canadian and U.S. markets, complementing their current liquid shot offerings in the Middle East. The move represents a calculated effort to grow the brand's presence through partnerships with local distributors who possess regional market expertise.
Delivra Health Brands Inc. (DHBUF) ha annunciato l'espansione del suo marchio Dream Water® nei mercati del Medio Oriente con il lancio delle nuove caramelle gommose per il sonno da 60 pezzi. Il prodotto sarà distribuito tramite il distributore dell'azienda con sede in Kuwait e si prevede che sarà disponibile nei mercati locali entro luglio 2025.
Questa espansione strategica si basa sul successo già consolidato delle caramelle gommose per il sonno di Dream Water nei mercati canadese e statunitense, integrando l'attuale offerta di shot liquidi nel Medio Oriente. Questa mossa rappresenta un tentativo calcolato di aumentare la presenza del marchio attraverso collaborazioni con distributori locali esperti del mercato regionale.
Delivra Health Brands Inc. (DHBUF) ha anunciado la expansión de su marca Dream Water® en los mercados del Medio Oriente con el lanzamiento de sus nuevas gomitas para dormir de 60 unidades. El producto será distribuido a través del distribuidor de la empresa con sede en Kuwait y se espera que esté disponible en los mercados locales para julio de 2025.
Esta expansión estratégica se basa en el éxito previo de las gomitas para dormir de Dream Water en los mercados de Canadá y EE. UU., complementando sus actuales productos líquidos en el Medio Oriente. La iniciativa representa un esfuerzo calculado para aumentar la presencia de la marca mediante asociaciones con distribuidores locales que cuentan con experiencia en el mercado regional.
Delivra Health Brands Inc. (DHBUF)는 새로운 60정 수면용 젤리 Dream Water® 브랜드를 중동 시장에 출시하며 확장한다고 발표했습니다. 이 제품은 쿠웨이트에 기반을 둔 회사의 유통업체를 통해 배포되며, 2025년 7월까지 현지 시장에서 판매될 예정입니다.
이번 전략적 확장은 캐나다와 미국 시장에서 이미 성공을 거둔 Dream Water의 수면 젤리 제품을 기반으로 하며, 중동 지역에서 현재 제공 중인 액상 제품과도 잘 어우러집니다. 이 조치는 지역 시장 전문 지식을 가진 현지 유통업체와의 파트너십을 통해 브랜드 입지를 확장하려는 계획적인 노력입니다.
Delivra Health Brands Inc. (DHBUF) a annoncé l'expansion de sa marque Dream Water® sur les marchés du Moyen-Orient avec le lancement de ses nouveaux gommes pour le sommeil en boîte de 60 unités. Le produit sera distribué via le distributeur de l'entreprise basé au Koweït et devrait être disponible sur les marchés locaux d'ici juillet 2025.
Cette expansion stratégique s'appuie sur le succès déjà établi des gommes pour le sommeil Dream Water sur les marchés canadien et américain, complétant ainsi leur offre actuelle de shots liquides au Moyen-Orient. Cette initiative représente un effort réfléchi pour accroître la présence de la marque grâce à des partenariats avec des distributeurs locaux possédant une expertise du marché régional.
Delivra Health Brands Inc. (DHBUF) hat die Erweiterung seiner Marke Dream Water® auf die Märkte im Nahen Osten bekannt gegeben, indem es neue 60er-Packung Schlaf-Gummis auf den Markt bringt. Das Produkt wird über den in Kuwait ansässigen Vertriebspartner des Unternehmens vertrieben und soll bis Juli 2025 in den lokalen Märkten erhältlich sein.
Diese strategische Expansion baut auf dem bereits bestehenden Erfolg der Dream Water Schlaf-Gummis in den kanadischen und US-amerikanischen Märkten auf und ergänzt das aktuelle Angebot an flüssigen Shots im Nahen Osten. Dieser Schritt stellt einen gezielten Versuch dar, die Markenpräsenz durch Partnerschaften mit lokalen Vertriebspartnern mit regionaler Marktexpertise auszubauen.
- Expansion into new Middle Eastern markets through established Kuwait-based distributor
- Product line expansion with new 60-Count Sleep Gummies format
- Building on existing success in Canadian and U.S. markets
- Diversification of product offerings in Middle East beyond liquid shots
- None.
Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Kuwait-based Dream Water® brand distributor is launching the Company's new 60-Count Sleep Gummies in Middle Eastern markets. The Company's 60-Count Sleep Gummies are expected to be available in the distributor's local markets by July 2025.
"This strategic product expansion aims to unlock new growth opportunities by partnering with local distributors who possess deep insights into their regional markets and have a proven ability to deliver strong performance," said Gord Davey, President and Chief Executive Officer of Delivra Health. "This global rollout of the 60-Count Sleep Gummies leverages the traction established by Dream Water® Sleep Gummies in both the Canadian and U.S. markets and reinforces the brand's growth strategy. This product format enhances our consumers' choice in Middle Eastern markets, complementing the current Dream Water® liquid shots that have been successful in providing sleep solutions."
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/2413/251339_965509706433aa9f_001full.jpg
About Delivra Health Brands Inc.
Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water® and LivRelief™, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are Dream Water® and LivReliefTM. For more information, please visit www.delivrahealthbrands.com.
Cautionary Note Regarding Forward-Looking Statements
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to timing of the availability of the 60-Count Sleep Gummies, the Company's growth opportunities in new and existing markets, and distribution channels for the 60-Count Sleep Gummies.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution; and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Company's management's discuss and analysis for the three and six months ended December 31, 2024 filed under the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251339